Nonoperating Income (Expense) in USD of UroGen Pharma Ltd. from 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
UroGen Pharma Ltd. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to Q3 2025.
  • UroGen Pharma Ltd. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$197K, a 24.7% decline year-over-year.
  • UroGen Pharma Ltd. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was -$727K, a 213% decline year-over-year.
  • UroGen Pharma Ltd. annual Nonoperating Income (Expense) for 2024 was -$229K, a 127% decline from 2023.
  • UroGen Pharma Ltd. annual Nonoperating Income (Expense) for 2023 was $838K, a 1064% increase from 2022.
  • UroGen Pharma Ltd. annual Nonoperating Income (Expense) for 2022 was $72K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

UroGen Pharma Ltd. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$727K -$197K -$39K -24.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$688K -$378K -$552K -317% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$136K -$90K +$93K +50.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 -$229K -$62K -$874K -108% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-10
Q3 2024 $645K -$158K -$229K -323% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $874K $174K +$204K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $670K -$183K -$168K -1120% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $838K $812K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-10
Q3 2023 $71K +$34K +91.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$30K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$15K -$11K -275% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 $37K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q1 2022 -$4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11

UroGen Pharma Ltd. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$229K -$1.07M -127% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 $838K +$766K +1064% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 $72K +$225K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$153K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.